{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:49:49Z","timestamp":1782222589207,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Medical and Health Science & Technology Project","award":["2022KY675"],"award-info":[{"award-number":["2022KY675"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50760-3","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:58:18Z","timestamp":1777348698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uptake in thyroid Tripterygium glycosides, enhances radioiodine cancer by promoting the expression and function of NIS"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhangguo","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"50760_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1320044","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao, S., Zhao, Y., Zhao, Y. & Wang, G. Pathogenesis and signaling pathways related to iodine-refractory differentiated thyroid cancer. Front. Endocrinol. (Lausanne) 14, 1320044. https:\/\/doi.org\/10.3389\/fendo.2023.1320044 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"50760_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/s2213-8587(14)70051-8","volume":"2","author":"C Spitzweg","year":"2014","unstructured":"Spitzweg, C., Bible, K. C., Hofbauer, L. C. & Morris, J. C. Advanced radioiodine-refractory differentiated thyroid cancer: The sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol. 2, 830\u2013842. https:\/\/doi.org\/10.1016\/s2213-8587(14)70051-8 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"50760_CR3","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.15.04113","volume":"15","author":"Q Jin","year":"2025","unstructured":"Jin, Q. et al. Global landscape of early-onset thyroid cancer: Current burden, temporal trend and future projections on the basis of GLOBOCAN 2022. J. Glob. Health 15, 04113. https:\/\/doi.org\/10.7189\/jogh.15.04113 (2025).","journal-title":"J. Glob. Health"},{"key":"50760_CR4","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante, C. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892\u20132899. https:\/\/doi.org\/10.1210\/jc.2005-2838 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"50760_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing, M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat. Rev. Cancer 13, 184\u2013199. https:\/\/doi.org\/10.1038\/nrc3431 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"50760_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan, F., Dedhia, P. H. & Ringel, M. D. Thyroid cancer, recent advances in diagnosis and therapy. Int. J. Cancer 149, 984\u2013992. https:\/\/doi.org\/10.1002\/ijc.33690 (2021).","journal-title":"Int. J. Cancer"},{"key":"50760_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa2111953","volume":"386","author":"S Leboulleux","year":"2022","unstructured":"Leboulleux, S. et al. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer. N. Engl. J. Med. 386, 923\u2013932. https:\/\/doi.org\/10.1056\/NEJMoa2111953 (2022).","journal-title":"N. Engl. J. Med."},{"key":"50760_CR8","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1210\/jc.2004-1414","volume":"89","author":"A Venkateswaran","year":"2004","unstructured":"Venkateswaran, A., Marsee, D. K., Green, S. H. & Jhiang, S. M. Forskolin, 8-Br-3\u2019,5\u2019-cyclic adenosine 5\u2019-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium\/iodide symporter protein levels in RET\/PTC1-expressing cells. J. Clin. Endocrinol. Metab. 89, 6168\u20136172. https:\/\/doi.org\/10.1210\/jc.2004-1414 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"50760_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s2213-8587(25)00064-6","volume":"13","author":"S Leboulleux","year":"2025","unstructured":"Leboulleux, S. et al. Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: An international thyroid oncology group statement. Lancet Diabetes Endocrinol. 13, 516\u2013527. https:\/\/doi.org\/10.1016\/s2213-8587(25)00064-6 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"50760_CR10","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/curroncol31070286","volume":"31","author":"F Volpe","year":"2024","unstructured":"Volpe, F. et al. Current advances in radioactive iodine-refractory differentiated thyroid cancer. Curr. Oncol. 31, 3870\u20133884. https:\/\/doi.org\/10.3390\/curroncol31070286 (2024).","journal-title":"Curr. Oncol."},{"key":"50760_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/js.2018-00180","volume":"2","author":"SN Rao","year":"2018","unstructured":"Rao, S. N. & Cabanillas, M. E. Navigating systemic therapy in advanced thyroid carcinoma: From standard of care to personalized therapy and beyond. J. Endocr. Soc. 2, 1109\u20131130. https:\/\/doi.org\/10.1210\/js.2018-00180 (2018).","journal-title":"J. Endocr. Soc."},{"key":"50760_CR12","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1078-0432.Ccr-23-0046","volume":"29","author":"S Leboulleux","year":"2023","unstructured":"Leboulleux, S. et al. A Phase II redifferentiation trial with Dabrafenib-Trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer. Clin. Cancer Res. 29, 2401\u20132409. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0046 (2023).","journal-title":"Clin. Cancer Res."},{"key":"50760_CR13","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1158\/0008-5472.Can-09-1248","volume":"69","author":"G Riesco-Eizaguirre","year":"2009","unstructured":"Riesco-Eizaguirre, G. et al. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 69, 8317\u20138325. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1248 (2009).","journal-title":"Cancer Res."},{"key":"50760_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2967\/jnumed.121.262402","volume":"63","author":"AM Avram","year":"2022","unstructured":"Avram, A. M., Zukotynski, K., Nadel, H. R. & Giovanella, L. Management of differentiated thyroid cancer: The standard of care. J. Nucl. Med. 63, 189\u2013195. https:\/\/doi.org\/10.2967\/jnumed.121.262402 (2022).","journal-title":"J. Nucl. Med."},{"key":"50760_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/cco.0000000000000797","volume":"34","author":"RS Scheffel","year":"2022","unstructured":"Scheffel, R. S., Dora, J. M. & Maia, A. L. BRAF mutations in thyroid cancer. Curr. Opin. Oncol. 34, 9\u201318. https:\/\/doi.org\/10.1097\/cco.0000000000000797 (2022).","journal-title":"Curr. Opin. Oncol."},{"key":"50760_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41574-019-0193-7","volume":"15","author":"S Starling","year":"2019","unstructured":"Starling, S. Key pathways revealed in rare thyroid cancer. Nat. Rev. Endocrinol. 15, 254\u2013255. https:\/\/doi.org\/10.1038\/s41574-019-0193-7 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"50760_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang, L. & Wei, W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol. Ther. 207, 107452. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107452 (2020).","journal-title":"Pharmacol. Ther."},{"key":"50760_CR18","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2025-0127","volume":"69","author":"I Finkel","year":"2025","unstructured":"Finkel, I. et al. BRAF inhibitor or BRAF\/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer. Arq. Bras. Endocrinol. Metabol. 69, e250127. https:\/\/doi.org\/10.20945\/2359-4292-2025-0127 (2025).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"50760_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12020-024-03845-w","volume":"86","author":"JN Priantti","year":"2024","unstructured":"Priantti, J. N. et al. Efficacy and safety of BRAF\/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: A systematic review and meta-analysis. Endocrine 86, 284\u2013292. https:\/\/doi.org\/10.1007\/s12020-024-03845-w (2024).","journal-title":"Endocrine"},{"key":"50760_CR20","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/dddt.S322502","volume":"15","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. Triptolide is a promising therapeutic approach in treating thyroid cancer based on in silico and in vitro experiment. Drug Des. Devel. Ther. 15, 4275\u20134287. https:\/\/doi.org\/10.2147\/dddt.S322502 (2021).","journal-title":"Drug Des. Devel. Ther."},{"key":"50760_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/482428","volume":"2013","author":"YF Chen","year":"2013","unstructured":"Chen, Y. F., Wu, K. J. & Wood, W. G. Paeonia lactiflora extract attenuating cerebral ischemia and arterial intimal hyperplasia is mediated by paeoniflorin via modulation of VSMC migration and Ras\/MEK\/ERK signaling pathway. Evid. Based Complement. Altern. Med. 2013, 482428. https:\/\/doi.org\/10.1155\/2013\/482428 (2013).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"50760_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.898955","volume":"13","author":"H Hong","year":"2022","unstructured":"Hong, H. et al. A review for the pharmacological effects of paeoniflorin in the nervous system. Front. Pharmacol. 13, 898955. https:\/\/doi.org\/10.3389\/fphar.2022.898955 (2022).","journal-title":"Front. Pharmacol."},{"key":"50760_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2020.113608","volume":"593","author":"L Pillai-Kastoori","year":"2020","unstructured":"Pillai-Kastoori, L., Schutz-Geschwender, A. R. & Harford, J. A. A systematic approach to quantitative Western blot analysis. Anal. Biochem. 593, 113608. https:\/\/doi.org\/10.1016\/j.ab.2020.113608 (2020).","journal-title":"Anal. Biochem."},{"key":"50760_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-2718-0_13","volume":"1314","author":"V Boveia","year":"2015","unstructured":"Boveia, V. & Schutz-Geschwender, A. Quantitative analysis of signal transduction with in-cell western immunofluorescence assays. Methods Mol. Biol. 1314, 115\u2013130. https:\/\/doi.org\/10.1007\/978-1-4939-2718-0_13 (2015).","journal-title":"Methods Mol. Biol."},{"key":"50760_CR25","first-page":"320","volume":"48","author":"E Sato","year":"2021","unstructured":"Sato, E. [Practical basis of immunohistochemical research and multiplexed immunohistochemistry]. Gan To Kagaku Ryoho 48, 320\u2013324 (2021).","journal-title":"Gan To Kagaku Ryoho"},{"key":"50760_CR26","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/erc-17-0515","volume":"25","author":"A De la Vieja","year":"2018","unstructured":"De la Vieja, A. & Santisteban, P. Role of iodide metabolism in physiology and cancer. Endocr. Relat. Cancer 25, R225-r245. https:\/\/doi.org\/10.1530\/erc-17-0515 (2018).","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"50760_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2011.09.022","volume":"48","author":"AF Leary","year":"2012","unstructured":"Leary, A. F. et al. Establishing an EGFR mutation screening service for non-small cell lung cancer - Sample quality criteria and candidate histological predictors. Eur. J. Cancer 48(1), 61\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2011.09.022 (2012).","journal-title":"Eur. J. Cancer"},{"key":"50760_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1142\/s0192415x18500489","volume":"46","author":"H Fu","year":"2018","unstructured":"Fu, H. et al. Hirsutella sinensis inhibits Lewis Lung Cancer via tumor microenvironment effector T cells in mice. Am. J. Chin. Med. 46, 911\u2013922. https:\/\/doi.org\/10.1142\/s0192415x18500489 (2018).","journal-title":"Am. J. Chin. Med."},{"key":"50760_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112136","volume":"244","author":"Q Shou","year":"2019","unstructured":"Shou, Q. et al. Total glucosides of peony improve ovalbumin-induced allergic asthma by inhibiting mast cell degranulation. J. Ethnopharmacol. 244, 112136. https:\/\/doi.org\/10.1016\/j.jep.2019.112136 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"50760_CR30","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1158\/0008-5472.Can-12-0516","volume":"72","author":"C Lacoste","year":"2012","unstructured":"Lacoste, C. et al. Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG. Cancer Res. 72, 5505\u20135515. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0516 (2012).","journal-title":"Cancer Res."},{"key":"50760_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.intimp.2012.07.012","volume":"14","author":"Z Zhou","year":"2012","unstructured":"Zhou, Z. et al. Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4\/5 signaling in vivo. Int. Immunopharmacol. 14, 275\u2013282. https:\/\/doi.org\/10.1016\/j.intimp.2012.07.012 (2012).","journal-title":"Int. Immunopharmacol."},{"key":"50760_CR32","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457-462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"50760_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"50760_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.intimp.2016.04.010","volume":"36","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Total glucosides of paeony (TGP) inhibits the production of inflammatory cytokines in oral lichen planus by suppressing the NF-\u03baB signaling pathway. Int. Immunopharmacol. 36, 67\u201372. https:\/\/doi.org\/10.1016\/j.intimp.2016.04.010 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"50760_CR35","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1101\/gad.424807","volume":"21","author":"TM Kitzing","year":"2007","unstructured":"Kitzing, T. M. et al. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev. 21, 1478\u20131483. https:\/\/doi.org\/10.1101\/gad.424807 (2007).","journal-title":"Genes Dev."},{"key":"50760_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/379458a0","volume":"379","author":"G Dai","year":"1996","unstructured":"Dai, G., Levy, O. & Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature 379, 458\u2013460. https:\/\/doi.org\/10.1038\/379458a0 (1996).","journal-title":"Nature"},{"key":"50760_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1349259","volume":"15","author":"M He","year":"2024","unstructured":"He, M., Hu, Z. & Yang, M. Effects of total glucosides of paeony on serum inflammatory cytokines in animal models of rheumatoid arthritis: A systematic review and meta-analysis. Front. Pharmacol. 15, 1349259. https:\/\/doi.org\/10.3389\/fphar.2024.1349259 (2024).","journal-title":"Front. Pharmacol."},{"key":"50760_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154307","volume":"104","author":"L Jin","year":"2022","unstructured":"Jin, L. et al. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-\u03baB\/CCL2 signaling. Phytomedicine 104, 154307. https:\/\/doi.org\/10.1016\/j.phymed.2022.154307 (2022).","journal-title":"Phytomedicine"},{"key":"50760_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.7150\/thno.3722","volume":"2","author":"BC Ahn","year":"2012","unstructured":"Ahn, B. C. Sodium iodide symporter for nuclear molecular imaging and gene therapy: From bedside to bench and back. Theranostics 2, 392\u2013402. https:\/\/doi.org\/10.7150\/thno.3722 (2012).","journal-title":"Theranostics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50760-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:04:21Z","timestamp":1782219861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50760-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50760"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50760-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have given their consent for the manuscript to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"19512"}}